166 related articles for article (PubMed ID: 37641872)
1. Bsep/Abcb11 knockout ameliorates Schistosoma mansoni liver pathology by reducing parasite fecundity.
Macháček T; Fuchs CD; Winkelmann F; Frank M; Scharnagl H; Stojakovic T; Sombetzki M; Trauner M
Liver Int; 2023 Nov; 43(11):2469-2478. PubMed ID: 37641872
[TBL] [Abstract][Full Text] [Related]
2. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
3. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Sombetzki M; Fuchs CD; Fickert P; Österreicher CH; Mueller M; Claudel T; Loebermann M; Engelmann R; Langner C; Sahin E; Schwinge D; Guenther ND; Schramm C; Mueller-Hilke B; Reisinger EC; Trauner M
J Hepatol; 2015 Apr; 62(4):871-8. PubMed ID: 25463533
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
[TBL] [Abstract][Full Text] [Related]
5. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M
Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis.
Loebermann M; Sombetzki M; Langner C; Fuchsbichler A; Gumhold J; Silbert D; Riebold D; Holtfreter M; Fickert P; Nizze H; Trauner M; Reisinger EC
Trop Med Int Health; 2009 Nov; 14(11):1418-25. PubMed ID: 19747186
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
8. Experimental infection with
Miranda GS; Rodrigues JGM; de Rezende MC; Resende SD; Camelo GMA; de Oliveira Silva JKA; Maggi L; Rodrigues VF; de Oliveira VG; Negrão-Corrêa DA
Parasitology; 2022 Sep; 149(11):1381-1396. PubMed ID: 35641335
[TBL] [Abstract][Full Text] [Related]
9. Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by
Maggi L; Camelo GMA; Rocha IC; Pereira Alves W; Moreira JMP; Almeida Pereira T; Tafuri WL; Rabelo ÉML; Correa A; Ecco R; Negrão-Corrêa DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373379
[No Abstract] [Full Text] [Related]
10. Probiotics and yogurt modulate oxidative stress and fibrosis in livers of Schistosoma mansoni-infected mice.
El-Khadragy MF; Al-Olayan EM; Elmallah MIY; Alharbi AM; Yehia HM; Abdel Moneim AE
BMC Complement Altern Med; 2019 Jan; 19(1):3. PubMed ID: 30606163
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
12. Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.
Said E; Said SA; Elkashef WF; Gameil NM; Ammar EM
Inflammopharmacology; 2012 Apr; 20(2):77-87. PubMed ID: 22278738
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.
El-Agamy DS; Shebl AM; Said SA
Inflammopharmacology; 2011 Dec; 19(6):307-16. PubMed ID: 21947519
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice.
Abd Allah MH; Zaalouk TK; Abo-Sheishaa GA; Shalash IR; Bayoumy AS
Egypt J Immunol; 2022 Oct; 29(4):174-183. PubMed ID: 36208046
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the liver pathology by the aqueous extract and the n-butanol fraction of Sida pilosa Retz in Schistosoma mansoni-infected mice.
Jatsa HB; Russo RC; Pereira CA; Aguilar EC; Garcia CC; Araújo ES; Oliveira JL; Rodrigues VF; de Oliveira VG; Alvarez-Leite JI; Braga FC; Louis-Albert Tchuem Tchuente ; Kamtchouing P; Negrão-Corrêa DA; Teixeira MM
J Ethnopharmacol; 2016 Mar; 180():114-23. PubMed ID: 26806570
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrotic Effect of Oral Versus Intraperitoneal Administration of Gold Nanoparticles in Hepatic Schistosoma mansoni-Infected Mice.
Ahmed SAA; Gad SEM; Eida OM; Makhlouf LM
Acta Parasitol; 2024 Mar; 69(1):190-202. PubMed ID: 37964174
[TBL] [Abstract][Full Text] [Related]
17. Preventive CTLA-4-Ig Treatment Reduces Hepatic Egg Load and Hepatic Fibrosis in
Sombetzki M; Rabes A; Bischofsberger M; Winkelmann F; Koslowski N; Schulz C; Reisinger EC
Biomed Res Int; 2019; 2019():1704238. PubMed ID: 31950032
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.
Elsakkar MG; Eissa MM; Hewedy WA; Nassra RM; Elatrebi SF
Life Sci; 2016 Oct; 162():95-101. PubMed ID: 27528511
[TBL] [Abstract][Full Text] [Related]
19. Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection.
Koslowski N; Sombetzki M; Loebermann M; Engelmann R; Grabow N; Österreicher CH; Trauner M; Mueller-Hilke B; Reisinger EC
PLoS Negl Trop Dis; 2017 May; 11(5):e0005595. PubMed ID: 28542175
[TBL] [Abstract][Full Text] [Related]
20. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice.
Maggi L; Rocha IC; Camelo GMA; Fernandes VR; Negrão-Corrêa D
Cytokine; 2021 Feb; 138():155390. PubMed ID: 33341001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
